Thalidomide in angiodysplasia-related bleeding

J. P. Boey, U. Hahn, S. Sagheer, S. J. Mcrae

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)


Gastrointestinal haemorrhage from angiodysplastic lesions is not only difficult to identify, but often refractory to endoscopic intervention. Patients often require substantial transfusion support. Thalidomide has emerged as a promising medical strategy in angiodysplasia-related bleeding. We present our experience and report the findings from a review of the literature. Despite its side-effect profile, thalidomide remains the therapeutic modality with the best evidence in this difficult clinical scenario.

Original languageEnglish
Pages (from-to)972-976
Number of pages5
JournalInternal Medicine Journal
Issue number9
Publication statusPublished - 1 Sept 2015
Externally publishedYes


  • Angiodysplasia
  • Gastrointestinal haemorrhage
  • Thalidomide
  • Von willebrand disease


Dive into the research topics of 'Thalidomide in angiodysplasia-related bleeding'. Together they form a unique fingerprint.

Cite this